GlassScriptPhysician profile
Turner Emery
NPI 1972676039
$7,261.10
in general payments reported to CMS, 2019-2025
9 companies · $594 in 2025
The $594 reported for 2025 was more than what 81% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $778 · 2021: $2,050 · 2022: $663 · 2023: $1,006 · 2024: $1,334 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,533 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,533.27 |
| Education | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,528.78 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,853.84 | 2019-2021 | |
| Straumann USA LLC | $1,585.97 | 2019-2025 | |
| Neoss, INC. | $698.00 | 2021 | |
| Salvin Dental Specialties, INC. | $240.70 | 2019-2021 | |
| Stryker Corporation | $144.36 | 2024 | Delta |
| Kls-Martin L.P. | $142.46 | 2021 | |
| Boston Scientific Corporation | $53.87 | 2025 | Apollo Esg Nxt System |
| Keystone Dental INC. | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Turner Emery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.